AgriTech Startup Funding 2025-2026

What are all the funding deals in the AgriTech market from August 2025 to September 2026?

The table below lists the qualifying disclosed equity rounds raised by pure-play AgriTech companies from August 2025 through September 2026. We define the AgriTech market as technologies purpose-built to improve agricultural production and input performance up to the farm gate, including precision agriculture, automation, sensors, farm-management technology, agricultural biologicals, crop genetics, crop protection, fertilizers, animal health and feed technologies.

Downstream food processing, food retail, consumer applications and generic logistics, fintech or enterprise software are excluded unless they are specifically designed around agricultural production. For a broader view of the companies, categories and investment themes shaping the sector, see our AgriTech market report.

How active has fundraising been in the AgriTech market?

As of September 2026, fundraising in the AgriTech market remains active but highly uneven in dollar terms. Over the past 12 months, the study records 54 qualifying disclosed equity deals and approximately $1.041B in capital raised.

The dataset averages 3.86 deals per calendar month and approximately $74.35M of capital per month. The median month is much lower at three deals and approximately $30.85M, showing that a few exceptional months materially lift the averages.

March 2026 is the clearest example. Roughly $377.5M was raised across ten transactions, with Halter and Tropic accounting for most of the month's unusually high capital total.

September 2026 is only represented through September 2, so the monthly run-rate should not be interpreted literally. For a wider view of current fundraising activity and company positioning, see our AgriTech funding and market report.

How concentrated has fundraising been in the AgriTech market?

As of September 2026, fundraising in the AgriTech market is strongly concentrated in a small group of large transactions. Over the past 12 months, the largest deal represents 21.14% of total capital, while the top three deals represent 41.31%.

The five largest rounds collectively account for 52.74% of all disclosed capital. The top ten reach 65.89%, meaning fewer than one-fifth of transactions absorb almost two-thirds of the money.

Halter's $220M financing is the largest individual contributor. Ecorobotix and Tropic follow at $105M each, giving those three companies approximately 41.3% of market funding by themselves.

This concentration makes aggregate funding a weak standalone indicator of market breadth. Deal count, median round size and capital excluding megarounds provide a more representative view of financing conditions.

How much of the AgriTech funding signal is driven by outliers?

As of September 2026, more than half of the headline AgriTech funding signal is driven by a very small number of outliers. Over the past 12 months, just five rounds above $50M generated approximately $549M, or 52.7% of disclosed capital.

Removing those financings leaves approximately $491.9M across the rest of the dataset. Five transactions therefore raised more money than the other 49 qualifying rounds combined.

Only 9.26% of transactions are $50M or larger, and only three rounds exceed $100M. Those three alone represent approximately 41.3% of all capital.

The practical reading rule is simple: a rise in AgriTech aggregate funding does not automatically mean funding conditions improved broadly. A deeper breakdown of this concentration is available in our AgriTech market analysis.

Is the AgriTech market broad with many fundable targets, or narrow with few companies?

As of September 2026, the AgriTech market is broad at the company-formation level but much narrower at the large-check level. Over the past 12 months, 54 qualifying transactions came from 54 different companies across six distinct technology categories.

Most rounds remain comparatively modest. Fourteen transactions are below $5M and another 29 sit from $5M to below $20M, so 43 of 54 deals are smaller than $20M.

The breadth also appears technologically. Agricultural Biologicals include genetics, crop protection, dsRNA, microbiome-derived molecules, biological frost protection, gene editing and new herbicidal modes of action.

The market becomes much narrower when investors move into scale capital. Every deal above $50M is a follow-on financing, which means large checks remain concentrated among companies that have already demonstrated substantial technical or commercial progress.

Is AgriTech mostly an early-stage formation market or a late-stage scaling market?

As of September 2026, the AgriTech market is early-stage by deal count but late-stage by capital allocation. Over the past 12 months, Seed represents 20 deals and Series A another 12, together accounting for 59.26% of qualifying transactions.

Those stages do not dominate the dollars. Seed accounts for approximately $118.9M and Series A for $197.6M, while Series B, Series C, Series D+ and Growth Equity collectively account for approximately $685.6M.

Using known-stage capital only, early-stage financing represents 31.58% of dollars and later-stage financing represents 68.42%. Series D+ alone accounts for 33.15% of all capital despite representing only three deals.

This means AgriTech is still generating new technical bets, but major capital becomes available only after validation. For more detail on the stage structure, see our AgriTech investment report.

Which categories attract the most investor attention in AgriTech?

As of September 2026, Agricultural Biologicals attract the most investor attention by transaction count in the AgriTech market. Over the past 12 months, the category produced 17 deals, representing 31.48% of all qualifying financings.

Farm Automation Systems rank second with 14 deals, or 25.93%. Precision Agriculture Tools and Farm Sensing Platforms each contribute seven deals, while Animal Health Technologies contribute five and Farm Management Software four.

The biologicals category is particularly broad. Investors are funding crop genetics, biological crop protection, gene editing, disease resistance, alternative herbicidal modes and fertilizer innovation rather than converging around one technical solution.

Automation activity is similarly diversified across virtual fencing, autonomous field robots, greenhouse harvesting, machinery autonomy and precision weeding. The repeated theme is direct control over labor or another measurable production cost.

Which categories attract disproportionately large checks in the AgriTech market?

As of September 2026, Farm Automation Systems attract the most disproportionately large checks in the AgriTech market. Over the past 12 months, the category captures 36.16% of capital from 25.93% of deals, producing a 1.39x capital-share-to-deal-share ratio.

Animal Health Technologies and Precision Agriculture Tools each sit at approximately 1.08x. Their shares of capital are therefore modestly larger than their shares of transaction count.

Agricultural Biologicals sit below parity at 0.92x despite leading on deal count. Farm Management Software and Farm Sensing Platforms are substantially more capital-light at 0.54x and 0.53x respectively.

Automation's apparent advantage should still be stress-tested. Halter alone contributes $220M of the category's $376.4M, so excluding that single transaction reduces automation funding to roughly $156M. We examine these category economics further in our AgriTech market report by category.

Which geographies matter most for fundraising in the AgriTech market?

As of September 2026, Europe is the most important geography for fundraising in the AgriTech market. Over the past 12 months, Europe produced 27 qualifying deals and approximately $589.72M, representing 50.00% of transactions and 56.66% of capital.

Asia-Pacific ranks second on dollars with approximately $273.10M from eight deals, or 26.24% of capital. North America produces many more transactions at 17 but only approximately $163.05M, or 15.66% of dollars.

The regional averages illustrate the distortion created by large transactions. Asia-Pacific averages approximately $34.14M per deal but has a median around $6M because Halter's $220M round pulls the mean sharply upward.

North America's average round is approximately $9.59M, less than half Europe's $21.84M. This suggests North American activity in the dataset is disproportionately concentrated in smaller early- and mid-stage financings.

Is the AgriTech opportunity set geographically broad or concentrated in one hub?

As of September 2026, the AgriTech opportunity set is geographically concentrated but not dominated by a single hub. Over the past 12 months, Europe, Asia-Pacific and North America collectively account for 98.56% of disclosed capital.

Europe has the deepest combination of volume and dollars, supporting automation, crop genetics, biological crop protection, sensing and animal technologies. Asia-Pacific has fewer transactions but benefits from the single largest financing in the dataset.

The Middle East contributes only two qualifying financings totaling $15M. Both are $7.5M transactions and target globally relevant production problems rather than purely local agricultural niches.

Latin America and Africa record no qualifying disclosed transactions in this dataset. That absence should not be confused with an absence of agricultural demand; it signals a gap between agricultural importance and publicly disclosed venture-scale AgriTech financing.

Is AgriTech a market of small experiments or scaled financings?

As of September 2026, the AgriTech market is primarily a market of modest technical and commercial financings with a thin layer of very large scale-up rounds. Over the past 12 months, the median financing is approximately $8.65M while the average reaches approximately $19.28M.

Fourteen rounds are below $5M, 29 are between $5M and below $20M, and six are between $20M and below $50M. Only five transactions reach $50M or more.

The average being more than 2.2 times the median confirms a strongly right-skewed distribution. The typical company is not raising a $20M-plus round even though headline funding totals can make the market appear much larger.

The real financing jump appears after commercial validation. Median Seed and Series A rounds are approximately $5.13M and $10.55M, while Series C and Series D+ financings rise sharply. For a deeper view of these financing thresholds, see our full AgriTech market report.

Who are the investors that appear the most in AgriTech fundraising?

As of September 2026, Corteva or Corteva Catalyst is the clearest repeat investor in the AgriTech market. Over the past 12 months, it appears in four qualifying financings: Ascribe Bio, Resurrect Bio, Tropic and Rainbow Crops.

Oyster Bay Venture Capital appears in three financings through Amatera, eternal.ag and Stenon. GrainInnovate appears in at least two and potentially three transactions depending on how entities are consolidated across SwarmFarm, BioScout and TerraBlaster disclosures.

Pymwymic, Demea Sustainable Investment, FCC or FCC Capital, Founders Fund, PINC, AgFunder, iSelect, Builders VC and Artesian each appear at least twice under the dataset's conservative entity-matching approach.

Corteva's pattern is particularly informative because its investments span multiple biological mechanisms rather than one technology. The company appears to be building optionality across disease resistance, biological crop protection, gene-edited traits and multiplex genome editing.

Investor participation should not be confused with individual check size. Financing announcements generally identify participants but rarely disclose each investor's contribution, so round-level dollars cannot reliably be attributed to a specific fund.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.